A detailed history of Castleview Partners, LLC transactions in Spdr Ser Tr Spdr S&P Pharmaceu stock. As of the latest transaction made, Castleview Partners, LLC holds 242 shares of XPH stock, worth $10,505. This represents 0.01% of its overall portfolio holdings.

Number of Shares
242
Previous 242 -0.0%
Holding current value
$10,505
Previous $10,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$39.59 - $44.52 $9,422 - $10,595
238 Added 5950.0%
242 $10,000
Q2 2022

Aug 17, 2022

SELL
$38.15 - $46.44 $387,604 - $471,830
-10,160 Reduced 99.96%
4 $0
Q2 2022

Aug 16, 2022

BUY
$38.15 - $46.44 $378,524 - $460,777
9,922 Added 4100.0%
10,164 $0
Q1 2022

May 16, 2022

SELL
$41.55 - $46.61 $453,975 - $509,260
-10,926 Reduced 97.83%
242 $10,000
Q4 2021

Feb 17, 2022

BUY
$43.72 - $52.45 $477,684 - $573,068
10,926 Added 4514.88%
11,168 $0
Q2 2021

Aug 17, 2021

BUY
$48.16 - $53.09 $11,654 - $12,847
242 New
242 $13,000

Others Institutions Holding XPH

About SPDR SER TR SPDR S&P PHARMACEU


  • Ticker XPH
  • Sector ETFs
  • Industry ETFs
More about XPH
Track This Portfolio

Track Castleview Partners, LLC Portfolio

Follow Castleview Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleview Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleview Partners, LLC with notifications on news.